1,4-dihydropyridine has been researched along with Heart Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catterall, WA; Fu, Y; Scheuer, T; Westenbroek, RE | 1 |
| Birkenhäger, WH; Bulpitt, CJ; Celis, H; de Leeuw, PW; Fagard, R; Fletcher, AE; Forette, F; Leonetti, G; McCormack, P; Nachev, C; O'Brien, E; Rodicio, JL; Rosenfeld, J; Sarti, C; Staessen, JA; Thijisq, L; Tuomilehto, J; Webster, J; Yodfat, Y; Zanchetti, A | 1 |
| Knaus, EE; Velázquez, C | 1 |
| Vetrovec, GW | 1 |
| Clair, MJ; Cox, MH; de Gasparo, M; Hebbar, L; Iannini, JP; Melton, DM; Mukherjee, R; Spinale, FG; Thomas, PB; Whitebread, S | 1 |
| Hoischen, S; Hullin, R; Reuter, H; Schwinger, RH | 1 |
| Bosnjak, ZJ; Contney, SJ; Kwok, CS; Nicolosi, AC; Olinger, GN | 1 |
| Frey, MJ; Lanoce, V; Liang, BT; Manning, DR; Marzo, KP; Molinoff, PB; Wilson, JR | 1 |
1 trial(s) available for 1,4-dihydropyridine and Heart Failure
| Article | Year |
|---|---|
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Incidence; Linear Models; Male; Myocardial Infarction; Nitrendipine; Stroke; Survival Rate; Time Factors; Treatment Outcome | 2004 |
7 other study(ies) available for 1,4-dihydropyridine and Heart Failure
| Article | Year |
|---|---|
Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Amino Acid Substitution; Animals; Arrhythmias, Cardiac; Barium; Calcium; Calcium Channels, L-Type; Cardiomyopathy, Hypertrophic; Casein Kinase II; Dihydropyridines; Exercise Tolerance; Heart Failure; Ion Transport; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Molecular; Mutation, Missense; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Point Mutation; Protein Conformation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Signal Transduction; Transfection | 2014 |
Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure.
Topics: Animals; Azo Compounds; Dihydropyridines; Drug Evaluation, Preclinical; Guinea Pigs; Heart Failure; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Muscle, Smooth; Nitric Oxide Donors; Spectrophotometry, Infrared | 2004 |
Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
Topics: Amlodipine; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Electrophysiology; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Myocardial Contraction; Myocardial Ischemia; Ventricular Function, Left | 1994 |
Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Calcium Channels; Calcium Channels, L-Type; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cell Membrane; Cells, Cultured; Dihydropyridines; Heart Failure; Myocardial Contraction; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Sarcoplasmic Reticulum; Sodium-Potassium-Exchanging ATPase; Swine; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 1997 |
Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
Topics: Adolescent; Adult; Aged; Binding Sites; Blotting, Northern; Blotting, Western; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calsequestrin; Cardiomyopathy, Dilated; Dihydropyridines; Dose-Response Relationship, Drug; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardium; Nifedipine; Tissue Distribution | 1999 |
Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Gadolinium; Guinea Pigs; Heart Failure; Hypoxia; In Vitro Techniques; Ion Channel Gating; Muscle Contraction; Nifedipine; Oxygen; Papillary Muscles | 2001 |
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Electric Stimulation; GTP-Binding Proteins; Heart Failure; Heart Rate; Hemodynamics; Pertussis Toxin; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1991 |